Cognizant (CTSH) says insurers will pay $5.5m in FCPA suit

Cognizant Technology Solutions (CTSH) disclosed in an SEC filing dated July 10 that insurers for defendants in a shareholder derivative case will pay the company $5.5 million under a proposed settlement tied to the IT services group’s Foreign Corrupt Practices Act fallout. A hearing before the U.S. District Court for the District of New Jersey is set for Sept. 14.

The cash figure is modest for Cognizant. It still gives investors a new marker for the clean-up of an older compliance scandal. In a settlement notice filed as Exhibit 99.1, the company said the money would come from insurers and return to Cognizant, the nominal defendant in the derivative action, rather than require a new corporate payment. That distinction makes the notice a governance-cost update, not an operating signal.

According to the settlement notice, the stockholder derivative case stems from allegations linked to Cognizant’s FCPA matter. Shareholders tied their claims to alleged bribery conduct, disclosure issues and share repurchases they said were completed at inflated prices. Cognizant did not present the document as a business update or earnings development; it laid out the court steps for resolving the governance suit.

“Defendants shall cause their insurers to pay to Cognizant a sum of $5.5 million.”

Settlement notice, SEC filing

Derivative litigation is brought on the company’s behalf, rather than as a direct class-wide investor payout. That is why the settlement consideration is slated to return to Cognizant. The $5.5 million is a governance recovery more than a fresh operating charge, even though the dispute grew out of the same allegations that produced earlier enforcement and disclosure fallout. The headline number says little about demand, margins or client spending.

Plaintiff’s counsel plan to seek up to $1.83 million in attorneys’ fees and expenses from the settlement consideration. Shareholders who want to object must do so by Aug. 31, according to the notice. The New Jersey federal court is due to hold the settlement hearing at 11 a.m. on Sept. 14, giving investors a procedural checkpoint while leaving the commercial stakes for the operating business limited.

Why the filing matters

The insurance funding is central. Directors’ and officers’ policies can absorb part of the financial tail from a governance case years after the central misconduct allegations have been resolved. Here, the proposed payment would come from insurers and return to Cognizant, pointing to a limited direct balance-sheet effect from this settlement itself. The FCPA episode remains a reputational and legal overhang.

The form of the case also matters. The derivative notice focuses on corporate recovery and governance terms, not a broad investor damages pool. Its fee request and hearing schedule show how clean-up costs can move across courts, plaintiffs and insurance towers after an original enforcement action. Legal exposure can shrink, change form and still produce new cash numbers years after the first allegations surface.

Another figure in the filing sets the scale. Cognizant also references litigation tied to the same episode, including a separate $95 million securities settlement previously disclosed by the company. The SEC filing and the exhibit point to an afterlife of earlier accusations, with shareholders using the corporate-governance route to pursue recovery tied to oversight and disclosure practices.

“The Settlement Hearing will be held… on SEPTEMBER 14, 2026, at 11:00 a.m.”

Settlement notice, SEC filing

Markets readers get a number, a timetable and a funding source for one remaining branch of Cognizant’s FCPA-related litigation. The documents stop short of signalling fresh pressure on revenue, guidance or client demand. It is a legal and governance update rather than an operating one, but the filing shows how large compliance cases can keep producing settlement costs and court dates after the first enforcement headlines fade.